美股異動丨奈飛創歷史新高,上半年累漲50%,在美股前20大市值股中漲幅排名第一
延續強勢,奈飛(NFLX.US)昨晚一度漲1.36%報1341.15美元,再創歷史新高,最終收漲1.21%報1339.13美元,創收盤歷史新高,市值達5699億美元。奈飛上半年累漲50.24%,在美股前20大市值股中漲幅排名第一。據最新消息,美國國家航空航天局(NASA)週一宣佈與流媒體平臺Netflix達成合作,通過Netflix向全球觀衆提供NASA+免費直播。自今年夏季起,用戶可在該平臺收看火箭發射直播、宇航員出艙及太空行走、任務實況及國際空間站拍攝的地球壯美實景。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.